This list is an analysis based on recent market events. It's not an investment recommendation.
About
Simcere Pharmaceutical Group Limited, an investment holding company, engages in the research, development, manufacture, and sale of pharmaceutical products to distributors, pharmacy chains, and other pharmaceutical manufacturers in China. The company focuses on various therapeutic areas, including oncology, central nervous system, autoimmune, anti-infection, cardiovascular, and others. Its principal products include Sanbexin, an edaravone and dexborneol concentrated solution for injection; Endostar, a recombinant human endostatin injection; ENWEIDA, an envafolimab injection; COSELA, a trilaciclib hydrochloride for injection; Iremod, an iguratimod tablet; and XIANNUOXIN simnotrelvir tablets and ritonavir tablets. The company also offers promotional services for pharmaceutical products. In addition, it engages in the manufacture of pharmaceutical ingredients and its property management business. The company was founded in 1995 and is headquartered in Nanjing, China.
What is Simcere Pharmaceutical Group Limited stock price today?▼
The current price of SMHGF is $1.49 USD — it has increased by +96.37% in the past 24 hours. Watch Simcere Pharmaceutical Group Limited stock price performance more closely on the chart.
What is Simcere Pharmaceutical Group Limited stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Simcere Pharmaceutical Group Limited stocks are traded under the ticker SMHGF.
Is Simcere Pharmaceutical Group Limited stock price growing?▼
SMHGF stock has risen by +96.37% compared to the previous week, the month change is a -24.01% fall, over the last year Simcere Pharmaceutical Group Limited has showed a +96.37% increase.
When is the next Simcere Pharmaceutical Group Limited earnings date?▼
Simcere Pharmaceutical Group Limited is going to release the next earnings report on August 21, 2026.
What is Simcere Pharmaceutical Group Limited revenue for the last year?▼
Simcere Pharmaceutical Group Limited revenue for the last year amounts to 911.12M USD.
What is Simcere Pharmaceutical Group Limited net income for the last year?▼
SMHGF net income for the last year is 100.74M USD.
Does Simcere Pharmaceutical Group Limited pay dividends?▼
Yes, SMHGF dividends are paid annual. The last dividend per share was 0.02 USD. As of today, Dividend Yield (FWD)% is 1.5%.
When did Simcere Pharmaceutical Group Limited complete a stock split?▼
Simcere Pharmaceutical Group Limited has not had any recent stock splits.
Where is Simcere Pharmaceutical Group Limited headquartered?▼
Simcere Pharmaceutical Group Limited is headquartered in Nanjing, US.